| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.21 | 0.2 |